Finance

Lists
002826:SHE
Tibet Aim Pharm Inc
CNÂ¥16.48
-1.55%
(-0.26) 1D
Oct 15, 3:04:51 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002826...
Open
CNÂ¥16.44
High
CNÂ¥16.99
Low
CNÂ¥16.31
Mkt. cap
3.22B
Avg. vol.
3.42M
Volume
2.31M
Dividend
0.91%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 9, 2026
P/E ratio
25.32
52-wk high
CNÂ¥23.19
52-wk low
CNÂ¥14.65
EPS
CNÂ¥0.65
Shares outstanding
190.68M
No. of employees
405
Open
CNÂ¥16.44
High
CNÂ¥16.99
Low
CNÂ¥16.31
Mkt. cap
3.22B
Avg. vol.
3.42M
Volume
2.31M
Dividend
0.91%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 9, 2026
P/E ratio
25.32
52-wk high
CNÂ¥23.19
52-wk low
CNÂ¥14.65
EPS
CNÂ¥0.65
Shares outstanding
190.68M
No. of employees
405
News stories
From web sources and news partners
About Tibet Aim Pharm Inc
CEO-
Employees405
Founded2003
Headquarters-
SectorPharmaceutical industry
Websiteemyy.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
177.54M
147.29M
182.58M
177.05M
Cost of goods sold
27.76M
26.53M
31.99M
32.66M
Cost of revenue
27.76M
26.53M
31.99M
32.66M
Research and development expenses
7.64M
4.79M
599.92K
1.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
120.14M
104.13M
122.41M
111.42M
Operating expense
96.19M
143.90M
126.22M
115.86M
Total operating expenses
123.95M
170.43M
158.21M
148.52M
Operating income
53.59M
-23.14M
24.37M
28.53M
Other non operating income
-13.92K
821.38K
228.21K
212.08K
EBT including unusual items
53.05M
11.45M
24.91M
58.11M
EBT excluding unusual items
53.97M
-21.21M
24.97M
30.45M
Income tax expense
9.03M
91.36K
5.26M
11.08M
Effective tax rate
17.02%
0.80%
21.12%
19.06%
Other operating expenses
-31.68M
36.59M
2.79M
3.24M
Net income
44.21M
10.82M
19.65M
47.03M
Net profit margin
24.90%
7.34%
10.76%
26.56%
Earnings per share
-
-
-
-
Interest and investment income
704.13K
1.26M
402.27K
1.79M
Interest expense
-310.24K
-158.84K
-27.52K
-89.35K
Net interest expenses
393.89K
1.10M
374.75K
1.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
58.98M
-18.39M
29.12M
32.74M
Gain or loss from assets sale
-231.28K
231.32K
-
87.49K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps